Non-small-cell lung carcinoma

Artikelen filtered by tag "non-small-cell lung carcinoma"

The following articles contain the tag non-small-cell lung carcinoma:


Erlotinib (Tarceva®) was the first EGFR tyrokinase inhibitor to be authorized for the treatment of non-small-cell lung carcinoma (NSCLC). It enabled outpatient treatment, and has a more favourable adverse effects profile than the existing chemoth ...

In short Read article